tiprankstipranks
Cognition announces all participants completed final visit in SHIMMER study
PremiumThe FlyCognition announces all participants completed final visit in SHIMMER study
2M ago
Cognition Therapeutics provided an update on Phase 2 ‘SHINE’ study analysis
Premium
The Fly
Cognition Therapeutics provided an update on Phase 2 ‘SHINE’ study analysis
2M ago
Cognition Therapeutics Reports Promising Q3 2024 Results
Premium
Company Announcements
Cognition Therapeutics Reports Promising Q3 2024 Results
2M ago
Cognition Therapeutics supports Lewy Body Dementia Awareness Month
PremiumThe FlyCognition Therapeutics supports Lewy Body Dementia Awareness Month
4M ago
Cognition Therapeutics Highlights CT1812 Potential in CNS Disorders
Premium
Company Announcements
Cognition Therapeutics Highlights CT1812 Potential in CNS Disorders
4M ago
Cognition Therapeutics Shares Investor Presentation Update
Premium
Company Announcements
Cognition Therapeutics Shares Investor Presentation Update
5M ago
Cognition Therapeutics price target lowered to $7 from $10 at H.C. Wainwright
PremiumThe FlyCognition Therapeutics price target lowered to $7 from $10 at H.C. Wainwright
6M ago
Cognition Therapeutics price target lowered to $5 from $6 at Ladenburg
Premium
The Fly
Cognition Therapeutics price target lowered to $5 from $6 at Ladenburg
6M ago
Cognition Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Cognition Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100